ARTICLES BY WALTER COLASANTE
-
How Are Cell And Gene Therapies Changing Drug Development Models?7/12/2018
A range of factors — including small patient populations, complex manufacturing processes, and lack of specialized expertise — are positioned to both drive up costs and require new options for stakeholder engagement and risk sharing along the development pathway. New approaches in development are needed to support the next generation of novel drugs on the horizon.
-
What's The Right Pricing Strategy For Cell And Gene Therapies?5/15/2018
This article highlights the diverse interests and range of opinions about pricing innovative and often high-cost therapies, but also demonstrates that most players in the sector see an urgent need for new pricing models to accommodate cell and gene therapy products.
This website uses cookies to ensure you get the best experience on our website. Learn more